BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12910254)

  • 21. Simian virus 40 and pleural mesothelioma in humans.
    Strickler HD; Goedert JJ; Fleming M; Travis WD; Williams AE; Rabkin CS; Daniel RW; Shah KV
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):473-5. PubMed ID: 8781745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas.
    Priftakis P; Bogdanovic G; Hjerpe A; Dalianis T
    Anticancer Res; 2002; 22(3):1357-60. PubMed ID: 12168811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of an important role for SV40 in mesothelioma.
    Pass HI; Bocchetta M; Carbone M
    Thorac Surg Clin; 2004 Nov; 14(4):489-95. PubMed ID: 15559055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.
    Strickler HD;
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):523-32. PubMed ID: 11352864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey.
    De Rienzo A; Tor M; Sterman DH; Aksoy F; Albelda SM; Testa JR
    J Cell Biochem; 2002; 84(3):455-9. PubMed ID: 11813251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine.
    Rollison DE; Page WF; Crawford H; Gridley G; Wacholder S; Martin J; Miller R; Engels EA
    Am J Epidemiol; 2004 Aug; 160(4):317-24. PubMed ID: 15286016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
    Engels EA
    Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas.
    Rizzo P; Di Resta I; Stach R; Mutti L; Picci P; Kast WM; Pass HI; Carbone M
    Dev Biol Stand; 1998; 94():33-40. PubMed ID: 9776223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simian virus 40 and malignant mesothelioma (Review).
    Cerrano PG; Jasani B; Filiberti R; Neri M; Merlo F; De Flora S; Mutti L; Puntoni R
    Int J Oncol; 2003 Jan; 22(1):187-94. PubMed ID: 12469203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.
    Testa JR; Carbone M; Hirvonen A; Khalili K; Krynska B; Linnainmaa K; Pooley FD; Rizzo P; Rusch V; Xiao GH
    Cancer Res; 1998 Oct; 58(20):4505-9. PubMed ID: 9788590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of SV40 with human tumours.
    Jasani B; Cristaudo A; Emri SA; Gazdar AF; Gibbs A; Krynska B; Miller C; Mutti L; Radu C; Tognon M; Procopio A
    Semin Cancer Biol; 2001 Feb; 11(1):49-61. PubMed ID: 11243899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simian virus 40 transformation, malignant mesothelioma and brain tumors.
    Qi F; Carbone M; Yang H; Gaudino G
    Expert Rev Respir Med; 2011 Oct; 5(5):683-97. PubMed ID: 21955238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simian virus 40 and human tumors: It is time to study mechanisms.
    Carbone M
    J Cell Biochem; 1999 Dec; 76(2):189-93. PubMed ID: 10618636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma.
    Zekri AR; Bahnassy AA; Mohamed WS; Hassan N; Abdel-Rahman AR; El-Kassem FA; Gaafar R
    Pathol Int; 2007 Aug; 57(8):493-501. PubMed ID: 17610473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for an SV40 vaccine.
    Imperiale MJ; Pass HI; Sanda MG
    Semin Cancer Biol; 2001 Feb; 11(1):81-5. PubMed ID: 11243902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.
    Leithner K; Leithner A; Clar H; Weinhaeusel A; Radl R; Krippl P; Rehak P; Windhager R; Haas OA; Olschewski H
    Orphanet J Rare Dis; 2006 Nov; 1():44. PubMed ID: 17090323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests.
    Butel JS
    Bull World Health Organ; 2000; 78(2):195-8. PubMed ID: 10743284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of malignant pleural mesothelioma.
    Jaurand MC; Fleury-Feith J
    Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
    Strickler HD; Goedert JJ; Devesa SS; Lahey J; Fraumeni JF; Rosenberg PS
    J Natl Cancer Inst; 2003 Jan; 95(1):38-45. PubMed ID: 12509399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.